IRVINE, Calif., Feb. 15, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that Praxsyn’s corporate headquarters have been moved from Irvine, California to Las Vegas, Nevada.
The board of directors authorized the move of Praxsyn Corporation’s headquarters to Nevada in order to allow for the expansion of Praxsyn’s operations, the ability to secure a larger pharmacy facility in Nevada at a more competitive price, and the overall lower labor costs.
Greg Sundem, PXYN’s Chief Executive Officer, stated “I have moved to Nevada from California because I believe it is important to be physically at any new facility to oversee the day-to-day operations and to ensure a successful transition.”
The new facility provides ample space for collection operations; with our increased focus on products and services that will pay within a 30-day billing cycle. By changing the business model to a type of business that collects in a shorter amount of time, the company will have a more fiscally responsible financial model than the long collection cycle.
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients. Mesa Pharmacy, located in Irvine, California works to realize the vision of medical professionals to improve the lives of their patients. Mesa Pharmacy continues its operations and services in Irvine, California to provide patients with pharmaceutical treatments as prescribed by their doctors. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Praxsyn Corporation’s move to Las Vegas, Nevada, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
###
Media/Investor Contact: [email protected] 949-777-6112 ext 101


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



